Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany13472-85-0 5-Bromo-2-methoxypyridine 98%
5-Bromo-2-methoxypyridine
5-Bromo-2-methoxypyridine
5-Bromo-2-methoxypyridine

13472-85-0 5-Bromo-2-methoxypyridine 98%

Price Get Latest Price
Packge 1kg5kg10kg25kg
  • Min. Order:10kg
  • Time:2024-01-19

Product Details

  • Product Name5-Bromo-2-methoxypyridine
  • CAS No.13472-85-0
  • EINECS No.603-856-9
  • MFC6H6BrNO
  • MW188.02
  • AppearanceLiquidClear colorless to slightly yellow
  • density 1.453 g/mL at 25 °C (lit.)
  • Boiling point 80 °C/12 mmHg (lit.)
  • storage temp. Inert atmosphere,Room Temperature

Company Profile Introduction

Nandana Laboratories Pvt Ltd (NLPL) is established with a vision of creating world class services in the Pharmaceutical & Healthcare space by a team of Pharmaceutical Professionals with nearly 34 years of experience in the industry.

NLPL was established by a set of pharmaceutical professionals who have rich experience in pharmaceutical companies. We have expertise in  pharmaceutical products.

In our endeavour of understanding the needs of the patients, we develop and provide healthcare in the areas of

  • Anti-Retro viral (Anti-HIV)
  • Antihistamine
  • Antifungal
  • Anti-Diabetes
  • Anti-cancer (Oncology products)
  • Anti-hypertensive
  • Anti-inflammatory
  • Anti-psychotic
  • What we do?
     

    Nandana Laboratories Pvt Ltd (NLPL) is established with a vision of creating world class services in the Pharmaceutical & Healthcare space by a team of Pharmaceutical Professionals with nearly 34 years of experience in the industry.

    NLPL was established by a set of pharmaceutical professionals who have rich experience in pharmaceutical companies. We have expertise in  pharmaceutical products.

  • Since:2020-01-01
  • Address: No: 6-494/1, Dwaraka Nagar, Chintal, Hyderabad, Telangana-500055, India.
INQUIRY